An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, April 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 231 followers.

An evaluation of the budget impact of a new 20% subcutaneous immunoglo | CEOR https://t.co/UOubZqKPLd

Reply Repost Favourite